SMIM18: A Drug Target / Disease Biomarker (G100507341)

Target Name: SMIM18

NCBI ID: G100507341

Other Name(s): Small integral membrane protein 18 | SIM18_HUMAN | small integral membrane protein 18

SMIM18: A Drug Target / Disease Biomarker

SMIM18 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the IMP (inositol-dependent protein kinase) family, which is a group of proteins that play a critical role in intracellular signaling.

SMIM18 is known for its role in regulating the activity of various cellular signaling pathways, including the intracellular signaling pathway known as the insulin/IGF-1 signaling pathway. This pathway is involved in a wide range of physiological processes in the body, including growth, development, and metabolism.

SMIM18 is also known for its role in the regulation of cellular responses to stress, both acute and chronic. It has been shown to play a key role in the regulation of the stress response by activating the stress-responsive signaling pathway, which involves the production of stress hormones such as cortisol and adrenaline.

SMIM18 is a potential drug target because of its involvement in multiple signaling pathways that are involved in a wide range of diseases, including diabetes, heart disease, and neurodegenerative diseases. It is also a good candidate for biomarker discovery, as its expression has been shown to be associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the challenges in studying SMIM18 is its relatively high level of expression in various tissues, which can make it difficult to study its effects in specific contexts. However, research into SMIM18 has provided some important insights into its role in various biological processes, including its role in the regulation of the insulin/IGF-1 signaling pathway and its involvement in the stress response.

SMIM18 is a protein that has been shown to play a critical role in the regulation of various signaling pathways that are involved in a wide range of diseases. Further research is needed to fully understand its effects and its potential as a drug target.

Protein Name: Small Integral Membrane Protein 18

More Common Targets